5 day volume Average = 90,740
20 day volume Average = 67,280
90 day volume Average = 162,882
Add to wishlistAdded to wishlistRemoved from wishlist 0
Add to compare
4.6/10 (Expert Score)
Stock is rated as #4 in category BM Health Care
Fairly Valued. Reach or higher than intrinsic value.
PROS:
  • Profitable business
  • Small Dividend Payout
  • Positive Cash Company
  • Low Gearing Ratio
  • High Trading Liquidity
CONS:
  • Low Price-to-Tangible ratio

klse: Kotra Industries Bhd


Corporate Information

Board   : Main

Shariah : Shariah Compliant

Sector   : Pharmaceuticals Ringgit Consumer Healthcare

Address: 1, 2&3, Jalan TTC 12, Cheng Industrial Estate, , 75250, Melaka

Contact: +606-3362222

Website: https://www.kotrapharma.com/
 

Corporate Background

Kotra Industries Berhad makes therapeutic products including anti-inflammatory, analgesic, antacids, cold and antitussive, anthelmentics, antidiabetics, antiasthmatics dermatological preparations, mouth and throat preparations, antiameobics, antihistamines, anti-emetics, and antivertigo. The Company also p roduces OTC products, energy drink booster, and mineral water.

Forecast: KOTRA 0002

Market Capital (RM) 4, 242, 030, 483
Forecasted Profit or Loss (RM) 28, 393, 265
Estimated Future EPS (sen) 19.193
Perspective P/E ratio 16.152
Estimated Dividend Yield (%) 1.855
Adjusted NTA (RM) 1.31

Result

Quarter Report History

Date Revenue,k PBT,k Net Profit,k
20/11/20 34,627 2,492 2,479
14/08/20 36,763 4,174 7,905
22/05/20 46,507 7,630 7,617
05/02/20 48,889 8,941 8,899
28/11/19 39,568 5,181 5,136
22/08/19 39,802 5,583 6,525
17/05/19 40,729 5,210 5,167
19/02/19 45,006 4,875 4,830
22/11/18 47,013 5,696 5,673
21/08/18 44,298 5,653 5,574
14/05/18 44,559 3,697 3,666
13/02/18 46,442 4,252 4,208

Fundamental

Fundamental Analysis

Last 4 Quarter Revenue (RM’000) 166,786
Last 4 Quarter Net Profit (RM’000) 26,900
Last 4 Quarter EPS (sen) 18.76
Last 4 Quarter PER 17.05
Last 4 Quarter Dividend (sen) 0.04
Last 4 Quarter Dividend Yield (%) 0.01
Net Tangible Assets (RM) 1.31
Goodwill (RM) 0
Cash (RM’000) 49,330
Debt (RM’000) 32,300
Total Debt (RM’000) 63,390
Net Assets (RM’000) 189,850
Current Ratio 2.65
Quick Ratio 1.73
Cash Ratio 1.13

Technical

Technical Analysis

MACD (26 vs 12) -0.001
Exponential Moving Average 5 3.161
Exponential Moving Average 20 3.186
Exponential Moving Average 90 3.095
Relative Strength Index 14 0.50
Stochastic %D 3 0.16
Stochastic %K 14 0.16

9 reviews for KOTRA 0002

2.5 out of 5
0
0
4
1
1
Write a review
Show all Most Helpful Highest Rating Lowest Rating
  1. Avatar

    BURSA MALAYSIA

    For the quarter ended 30 June 2020, the Group recorded a decrease in revenue of 20.95% to RM36.76 million as compared to RM46.51 million in the preceding quarter. This was attributed to decrease in sales of health supplement to export markets and lower sales of pharmaceutical products to local markets.

    Helpful(0) Unhelpful(0)You have already voted this
  2. Avatar

    BURSA MALAYSIA

    For the quarter ended 31 March 2020, the Group recorded a decrease in revenue of 4.87% to RM46.51 million as compared to RM48.89 million in the preceding quarter. This was attributed to decrease in sales to export markets for both the health supplements products and pharmaceutical products.The Group recorded a profit before tax of RM7.63 million in the current quarter as compared to the profit before tax of RM8.94 million in the preceding quarter. Decrease in net profit before tax was mainly due to decrease in sales.

    Helpful(0) Unhelpful(0)You have already voted this
  3. Avatar

    INVESTING MALAYSIA

    12 MAR 20 – AmBank Research anticipates a flattish financial year 2020 (FY20) for KPJ Healthcare Bhd, amid expectations of higher tax and lower inpatient volume in the first half of this year.

    Helpful(0) Unhelpful(0)You have already voted this
  4. Avatar

    BURSA MALAYSIA

    For the quarter ended 31 December 2019, the Group recorded a revenue of RM48.89 million and profit before tax of RM8.94 million as compared to revenue of RM39.57 million and profit before tax of RM5.18 million in the preceding quarter. Increase in revenue was mainly due to higher sales derived from both the local and export markets for health supplements products and higher sales achieved for pharmaceutical products in export markets. Increase in net profit after tax was mainly due to increase in sales.

    Helpful(0) Unhelpful(0)You have already voted this
  5. Avatar

    Investing Malaysia

    Average investing volume for Kotra Industries Bhd in the past three months in stock market was 35.6k lots

    Helpful(0) Unhelpful(0)You have already voted this
  6. Avatar

    Investing Malaysia

    KOTRA gets a score of 14.82 in our equity and assets quality test based on current share price of RM2.19

    Helpful(0) Unhelpful(0)You have already voted this
  7. Avatar

    Investing Malaysia

    Kotra Industries Bhd gets a score of 18.93 in our stability test after the balance sheet, money statement study

    Helpful(0) Unhelpful(0)You have already voted this
  8. Avatar

    Investing Malaysia

    Stock code of 0002 in Bursa Malaysia declared adjusted 0.02% dividend yield in past few years

    Helpful(0) Unhelpful(0)You have already voted this
  9. Avatar

    Investing Malaysia

    KOTRA is estimated to have a profit consensus of 20.58 millions, with an adjusted market capitalization of 316.55 millions

    Helpful(0) Unhelpful(0)You have already voted this

    Add a review

    Your email address will not be published.

    Register New Account
    Name (required)
    Reset Password
    Compare items
    • Total (0)
    Compare